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Abstract Objective To investigate the occurrence and possible mechanisms of apoptosis in cochlear epithelium
and spiral ganglion neurons after mefloquine treatment. Methods We used quantitative RT-PCR apoptosis-fo⁃
cused gene arrays（96-well, 84 apoptosis related genes）to assess changes of gene expression in the cochlear basilar
membrane（hair cells-supporting cells）and spiral ganglion neurons of rat cochlear organotypic cultures treated with
100 μM mefloquine for 3 h. Results Significant up-or down-regulation in gene expression was detected in 23
genes in the cochlear basilar membrane, and in 32 genes in the spiral ganglion neurons compared with time-matched
controls. The responding genes could be classified as pro-or anti-apoptotic, and were mainly implicated in the
Bcl-2, Caspase, Card, IAP, TNF ligand／TNF receptor, Death domain／Death effector domain, DNA damage／p53,
and NF-kappa B families. Synthetic analysis suggested that these families could be revised to two major pathways
mainly involved in the death receptor-mediated signaling pathway and apoptotic mitochondrial pathway. In addition,
it was found that numerous anti-apoptotic genes such as Bcl2a1, Birc1b, Birc3, Birc4, Bnip1, Cflar, Il10, Lhx4,
Mcl1, Nfkb1, Prlr, Prok2, and TNF were greatly up-regulated in the cochlear tissue, which might imply the co-exis⁃
tence of protective response in the cells at the early stage of mefloquine-induced damage.
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Intrduction
Mefloquine is a potent antimalarial drug, widely used
for prophylactic and chemotherapeutic treatment of ma⁃
laria. As a synthetic analogue of quinine, the molecular
formula, the range of clinical application, and the
side-effect of mefloquine are similar to quinine. Howev⁃
er, the neurotoxic and psychiatric side-effects of meflo⁃
quine are more severe than quinine which include de⁃
pression, anxiety, paranoia, aggression, nightmares, in⁃
somnia, seizures, peripheral motor-sensory neuropathy,
and many problems in the central nervous system.1-10
Over the past years, there has been a growing concern
among government agencies about the adverse ototoxic
potential of mefloquine. 7, 9, 11-13 Based on these prelimi⁃
nary studies as well as limited clinical reports in the lit⁃
erature concerning the ototoxic and vestibulotoxic po⁃
tentials, the specific aim of this study is to evaluate
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mechanisms of mefloquine caused apoptosis in the co⁃
chlea.
Methods
Animals
Fischer-344（F344）rats at the age of postnatal day
3 were used. Experiments were performed according to
the rules and regulations of the Institutional Animal
Care and Use Committee of the State University of New
York at Buffalo and the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Cochlear membranous labyrinth dissection
Using techniques reported in our previous studies,
postnatal day 3 F344 rats were decapitated and the co⁃
chlear basilar membrane and spiral ganglion neurons in
Rosenthal’s canal were microdissected out in Hanks
Balanced Salt Solution（HBSS, Invitrogen）. 14, 15 Briefly,
the stria vascularis and spiral ligament were removed,
and the whole cochlear basilar membrane along with
the spiral ganglion neurons were dissected out under a
dissection microscope in HBSS. To separate the cochle⁃
ar basilar membrane containing the organ of Corti and
the Rosenthal’s canal containing spiral ganglion neu⁃
rons, the whole Rosenthal’s canal was further separated
along the inner edge of the basilar membrane.
Mefloquine treatment
Cochlear basilar membrane and Rosenthal’s canal
were incubated at 37℃ and 5% CO2 in a serum-free
medium, with or without 100 μM of mefloquine, in 35
mm polystyrene dishes（Falcon, Becton Dickinson,
Franklin Lakes, NJ）for 3 h. The serum-free medium
consisted of bovine serum albumin [Sigma A-4919] 2 g, Se⁃
rum-Free Supplement [Sigma I-1884] 2 ml, 20% Glucose [Sigma
G-2020] 4.8 ml, Penicillin G [Sigma P-3414] 0.4 ml, 200 mM Glu⁃
tamine [Sigma G-6392] 2 ml, and 1× BME [Sigma B-1522] 190.8 ml.
Fifteen cochlear basilar membrane specimens contain⁃
ing the organ of Corti, or fifteen Rosenthal’s canal spec⁃
imens containing spiral ganglion neurons were treated
in one dish. Mefloquine treated and non-treated speci⁃
mens were pooled from 15 cochleae to generate one
sample. Each sample was run separately for the
qRT-PCR analysis. Five samples were tested, totaling
150 cochleae from 75 rats.
Quantitative RT-PCR apoptosis-focused gene arrays
In this study, we assayed the epithelium of basilar
membrane containing the cochlear hair cells and sup⁃
porting cells with or without mefloquine treatment using
qRT-PCR array designed in 96-wells for the detection
of 84 key apoptosis related genes. Sample preparation
and the RT-PCR array determination were similar as
described in our previous publications.16-18 In brief, af⁃
ter 3 hours of culture with or without mefloquine, co⁃
chlear tissues were disrupted and homogenized in Buf⁃
fer RLT. Total RNA was isolated and extracted using an
RNA extraction kit（RNeasy Mini Kit, Qiagen）accord⁃
ing to manufacturer’s protocols. The solution contain⁃
ing extracted RNA was treated with RNase-Free DNase
（Qiagen, Catalog# 79254）to remove DNA contamina⁃
tion. After the initial extraction, the RNA solution was
cleaned up using RT2 qPCR-Grade RNA Isolation Kit
（SuperArray, catalog # PA-001）. The quantity of total
RNA was evaluated with a spectrophotometer（Beck⁃
man Coulter DU 640）. The amount of total RNA extract⁃
ed from 15 cochleae was 507.6 ± 51.2 μg in epithelium
of cochlear basilar membrane, and 291.2 ± 88.9 μg in
spiral ganglion neurons respectively. After the RNA ex⁃
traction and quality assessment, cDNA synthesis was
performed using the kit of cDNA Synthasis Master Mix
according to the manufacturer’s protocols, and then
cRNA amplification was performed using the kit of Am⁃
plification Master Mix in accordance with the manufac⁃
turer’s protocols. The RT2 Profiler PCR Array（SABio⁃
sciences, Frederick, MD, USA) was used to measure the
expression levels of apoptosis-related genes. Samples
were prepared with the Master Mix and Template Cock⁃
tail and loaded into the 96-well qRT2-PCR array.
RT2-qPCR arrays were run on BioRad MyiQ thermal
cycler using SYBR Green detection. Cycle thresholds
were determined for each gene using the instrument’s
software. Cycle threshold values were transferred into a
Data Analysis Template Excel file（SuperArray） and
ΔΔCt values determined for each gene in the meflo⁃
quine-treated and control array. Fold change in expres⁃
sion of each gene in Mefloquine was compared to Con⁃
trol array.
Results
Changes in expression of apoptosis related genes in
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epithelium of basilar membrane
After 3 h of mefloquine treatment, expression chang⁃
es were detected in 23 of the 84 studied genes. Expres⁃
sion was increased in 10 genes, but decreased in the
other 13 genes. The rest 61 genes showed no significant
change in comparison with untreated cochlear tissues.
The 10 genes showing increased expression were
Bcl2a1, Birc3, Gadd45a, Il10, Mcl1, Nfkb1, Prok2, Py⁃
card, Tnf, and Tnfsf6, and those showing decreased ex⁃
pression were Bid3, Birc4, Bnip1, Casp1, Casp7, Casp9,
Cradd, Faim, Prlr, Sphk2, Tnfsf10, Tnfsf12, and Tradd.
These genes are relevant to multiple apoptotic signaling
pathways, including the Bcl-2（Bcl2a1, Bid3, Bnip1,
Mcl1）, Caspase（Casp1, Casp7, Casp9）, TNF ligand /
receptor（Faim, Tnf, Tnfsf6, Tnfsf10, Tnfsf12, Il10,
Prok2, Sphk2, Tradd）, IAP（Birc3, Birc4）, Death do⁃
main／Death effector domain（Cradd, Tradd）, p53,
DNA damage-induced apoptosis（Casp7, Casp9, Cradd,
Gadd45a, Mcl1, Nfkb1, Pycard, Tnf, Tnfsf6, Tradd）,
NF-kappa B（Bcl2a1, Il10, Nfkb1, TNF, Tnfsf6,
Gene
Bcl2a1
Bid3
Birc3
Birc4
Bnip1
Casp1
Caps7
Casp9
Cradd
Faim
Gadd45a
Il10
Mcl1
Nfkb1
Prlr
Prok2
Pycard
Sphk2
Tnf
Tnfsf10
Tnfsf12
Tnfsf6
Tradd
Description
B-cell leukemia/lymphoma 2 related protein A1
BH3 interacting（with BCL2 family）domain, apoptosis agonist
Inhibitor of apoptosis protein 1
Baculoviral IAP repeat-containing 4
BCL2/adenovirus E1B 19kDa-interacting protein 1
Caspase 1
Caspase 7
Caspase 9
CASP2 and RIPK1 domain containing adaptor with death
domain (predicted)
Fas apoptotic inhibitory molecule
Growth arrest and DNA-damage-inducible 45 alpha
Interleukin 10
Myeloid cell leukemia sequence 1
Nuclear factor of kappa light chain gene enhancer in B-cells 1,
p105
Prolactin receptor
Homolog of mouse Bv8（Bombina variegata 8 kDa）; prokineticin
2 precursor
Apoptosis-associated speck-like protein containing a CARD
Sphingosine kinase 2
Tumor necrosis factor superfamily, member 2
Tumor necrosis factor（ligand）superfamily, member 10
Tumor necrosis factor ligand superfamily member 12
Tumor necrosis factor（ligand）superfamily, member 6
TNFRSF1A-associated via death domain
Functional Gene Grouping
Bcl-2 family
Bcl-2 family
IAP family
IAP family
Bcl-2 family
Caspase family / Card family
Caspase family / p53 family
Caspase family / p53 family / Card family
Death domain family / Card family / p53 family
TNF ligand / receptor family
p53 family
NF-kappa B family
Bcl-2 family / p53 family
p53 family / NF-kappa B family
Cytokine receptor family
TNF ligand / receptor family
Death domain family / p53 family
TNF ligand / receptor family
TNF ligand family / NF-kappa B family
TNF ligand family / NF-kappa B family
TNF ligand family / NF-kappa B family
TNF ligand family / p53 family / NF-kappa B family
TNF ligand /p53 / NF-kappa B / Death domain
Fold changes
3.63
-3.14
21.86
-2.14
-2.09
-2.43
-2.28
-2.08
-2.96
-2.37
2.69
5.68
4.37
2.15
-2.34
6.6
2.18
-2.01
19.08
-3.55
-2.83
4.6
-3.32
Table 1 The functional grouping and fold changes of responding genes in cochlear epithelium by mefloquine injury were as de⁃
scribed in table 1. The name of genes with bold italics written are anti-apoptotic genes, while the gene name with standard type are
pro-apoptotic genes.
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Tnfsf10, Tradd）, Card（Birc3, Birc4, Casp1, Casp9,
Cradd, Pycard）, and Cytokine receptor families（Prlr）.
They are either pro-apoptotic（Bid3, Casp1, Casp7,
Casp9, Cradd, Gadd45a, Pycard, Tnfsf6, Tnfsf10,
Tnfsf12, Tradd）or anti-apoptotic genes（Bcl2a1, Birc3,
Birc4, Bnip1, Faim, Il10, Mcl1, Nfkb1, Prlr, Prok2,
Sphk2, Tnf）（Table 1）（Figure 1）.
Changes in expressive of apoptosis related genes in
spiral ganglion neurons．
In the tissue of spiral ganglion neurons, 32 genes
showed changes in gene expression after mefloquine
treatment, with 25 showing increased expression and 7
showing decreased expression. There was no expression
change in the rest 52 genes. The 25 genes showing in⁃
creased expression were Apaf1, Bcl10, Bcl2a1,
Bcl2l11, Birc1b, Birc3, Casp14-predicted, Cflar,
Gadd45a, Il10, Lhx4-predicated, Lta, Nfkb1, Prok2,
Pycard, Ripk2, Tnf, Tnfrsf10b-predicted, Tnfrsf11b,
Tnfrsf1a, Tnfrsf6, Tnfsf5, Tnfsf6, Trp63, and
Trp73-predicted, and the 7 genes with decreased ex⁃
pression were Birc5, Card6-predicted, Casp9, Cradd,
Tnfsf10, Tnfsf12, Tradd. Nineteen of these genes are
pro-apoptotic（Apaf1, Bcl10, Bcl2l11, Card6-predicted,
Casp14-predicted, Casp9, Cradd, Gadd45a, Lta, Py⁃
card, Tnfrsf10b-predicted, Tnfrsf11b, Tnfrsf1a, Tnfsf10,
Tnfsf12, Tnfsf6, Tradd, Trp63, Trp73-predicted） and
the remaining 13 genes（Bcl2a1, Birc1b, Birc3, Birc5,
Cflar, Il10, Lhx4-predicated, Nfkb1, Prok2, Ripk2, Tnf,
Tnfrsf6, Tnfsf5）are anti-apoptotic genes. The multiple
apoptotic signals are involved in the following path⁃
ways: the Bcl-2 family（Bcl2a1, Bcl2l11）, Caspase fam⁃
ily（Casp14-predicted, Casp9）, IAP family （Birc1b,
Birc3, Birc5）, TNF ligand / receptor family （Lta,
Prok2, Tnf, Tnfsf5, Tnfsf6, Tnfsf10, Tnfsf12, Tn⁃
frsf10b-predicted, Tnfrsf11b, Tnfrsf1a, Tnfrsf6, Tradd）,
Death domain／Death effector domain family（Cflar,
Cradd, Tnfrsf11b, Tnfrsf6, Tradd）, Card family（Apaf1,
Bcl10, Birc3, Card6-predicted, Casp9, Cradd, Pycard,
Ripk2）, p53 family and DNA damage-induced apopto⁃
sis（Apaf1, Casp9, Cradd, Gadd45a, Nfkb1, Pycard,
Tnf, Tnfrsf10b-predicted, Tnfrsf6, Tnfsf6, Tradd, Trp63,
Trp73）, NF-kappa B family（Bcl10, Bcl2a1, Cflar,
Il10, Lta, Nfkb1, Ripk2, Tnf, Tnfrsf1a, Tnfrsf10b-pre⁃
dicted, Tnfsf6, Tnfsf10, Tradd）, and LIM-homeobox
gene family（Lhx4-predicated）（Table 2）（Figure 2）.
Discussion
RT-PCR（reverse transcription-polymerase chain reac⁃
tion）arrays are the most reliable tools for analyzing the
expression of a focused panel of genes for mRNA detec⁃
tion and quantification. Quantitative RT-PCR apopto⁃
sis-focused gene array is designed for analysis of ex⁃
pression of a panel of genes associated with numerous
apoptotic biological pathways. In current apoptosis fo⁃
cused qRT-PCR primer set, the qPCR primer assay has
been tested and validated for gene-by-gene expression
analysis and microarray data validation. Except the
housekeeping genes, the apoptosis RT-Profiler PCR ar⁃
ray profiles the expression of 84 key genes involved in
programmed cell death which covers the possessory
apoptotic pathways in the current study. Of the 84 test⁃
ed apoptosis-related key genes included in the RT2
Profiler PCR Array, 55 are pro-apoptotic genes and 29
are anti-apoptotic genes. Whether apoptotic or an⁃
ti-apoptotic, changes in expression of these genes are
generally indicative of cellular responses to stimuli of
specific apoptotic signals. Therefore, the early change
genes may indicate a response to the earliest apoptotic
signals, and their apoptotic pathways may be involved
in the primary apoptotic mechanisms. In contrast, the
unresponsive genes can be taken into account as indeci⁃
sive genes at the early stage, and their apoptotic path⁃
ways are supposed to be secondary apoptotic mecha⁃
nisms in mefloquine-induced cell apoptosis in the co⁃
Figure 1 Significant changes in gene expression in cochlear
epithelium 3 hours after 100 μm mefloquine treatment. The ex⁃
pression in 10 genes was increased, but the expression in an⁃
other 13 genes was decreased
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chlea.
Apoptosis is an occurring process to direct pro⁃
grammed cell self-destruction. Apoptosis generally can
occur through two major broad pathways: extrinsic and
intrinsic pathways. The extrinsic pathway begins out⁃
side of the cell when the cell determines to die as lethal
factors appear in extracellular environment, whereas
the intrinsic pathway begins when an injury occurs with⁃
in the cell. In our previous studies, we demonstrated
that mefloquine-induced apoptotic signaling in the co⁃
chlear hair cells and spiral ganglion neurons were asso⁃
ciated with activation of numerous caspases, particular⁃
ly the typical involvement of the mitochondrial pathway
with caspase-9 activation and cell death receptor-
Gene
Apaf1
Bcl10
Bcl2a1
Bcl2l11
Birc1b
Birc3
birc5
Card6-predicted
Casp14-predicted
Casp9
Cflar
Cradd
Gadd45a
II10
Lhx4-predicted
Lta
Nfkb1
Prok2
Pycard
Ripk2
Tnf
Description
Apoptotic peptidase activating factor1
B-cell/lymphoma 10
B-cell leukemia/lymphoma 2 related protein A1
BCL2-like 11（apoptosis facilitator）
Baculoviral IAP repeat-containing 1b
Inhibitor of apoptosis protein 1
Baculoviral IAP repeat-containing 5
Caspase recruitment domain, member 6
Caspase 14（predicted）
Caspase 9
CASP8 and FADD-like apoptosisregulator
CASP2 and RIPK1domain containing adaptor
with death domain（predicted）
Growth arrest and DNA-damage-inducible 45 alpha
Interleukin10
LIM homeobox protein 4（predicted）
Lymphotoxin A
Nuclear factor of kappa light chair gene enhancer
in B-cells1, p105
Prokineticin 2 precursor
Apoptosis-associated speck-like protein containing a CARD
Receptor（TNFRSF）-interacting serine-threonine kinase 2,
anti-apoptotic
Tumor necrosis factor superfamily, member 2
Functional Gene Grouping
Card family
Card family
Bcl-2family
Bcl-2family
IAP family
IAP family
IAP family
Caspase family/Card family
Caspase family
Caspase family/p53 family/
Card family
Death domain/Death effector
domain family
Death domain family/Card
family/p53 family
p53familu
NF-kappa Bfamily
LIM-homeobox gene family
TNFligand family/NF-kappa
B family
p53family/NF-kappa B
family
TNF ligand/receptor family
Death domain family/
p53family/caspase family
Card family
TNF ligand family/
NF-kappa B family
Fold changes
2.52
2.18
11.75
3.07
5.07
47.5
-2.3
-2.2
22.35
-2.13
2.81
-2.11
6.82
21.65
11.7
26.83
7.15
19.89
2.42
4.15
25.71
pvalue
0.0021
0.0026
<0.0001
0.0053
<0.0001
<0.0001
0.004
0.0114
<0.0001
0.0231
0.0002
0.0009
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
Table 2 The functional grouping and fold changes of responding genes in cochlear spiral ganglion neurons by mefloquine injury
were as described in table 2. The name of genes with bold italics written are anti-apoptotic genes, while the gene name with stan⁃
dard type are pro-apoptotic genes
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mediated signaling pathway with caspase-8
activation.12, 13, 19-21 This indicates that the intracellular
organs, such as mitochondria and cell death receptors,
were injured internally by mefloquine. Generally speak⁃
ing, mefloquine-induced intracellular apoptotic signal⁃
ing following caspase activation should be classified as
both extrinsic, involving responses from cell death re⁃
ceptors on the cell membrane, and intrinsic, involving
responses from mitochondrial apoptotic pathway.
The findings in the current study show that numerous
genes and multiple apoptotic pathways are involved in
mefloquine-induced apoptosis in both cochlear epitheli⁃
um and spiral ganglion neurons. The early responding
apoptotic genes in response to mefloquine injury mostly
involve the Bcl-2 family, Caspase family, Card family,
TNF ligand and TNF receptor family, IAP family, Death
domain and Death effector domain family, DNA damage
and p53 family, and NF-kappa B family. According to
their functional configurations, one gene directly or indi⁃
rectly belongs to or is related to several apoptotic fami⁃
lies. Therefore, altered genes may arouse multiple apop⁃
totic pathways. To better understand potential relations
among these functional gene groupings, we examined in⁃
teractions among the responding genes. Most respond⁃
ing genes in the TNF ligand / TNF receptor family are
Gene
Tnfrsf10b-predicted
Tnfrsf11b
Tumor necrosis factor receptor
superfamily, member 1a
Tnfrsf6
Tnfsf10
Tnfsf12
Tnfsf5
Tnfsf6
Tradd
Trp63
Trp73-predicted
Description
Tumor necrosis factor receptor superfamily,
member 10b（predicted）
Tumor necrosis factor receptor superfamily,
member 11b（osteoprotegerin）
Tumor necrosis factor receptor superfamily,
member1a
Tumor necrosis factor receptor superfamily,
member6
Tumor necrosis factor（ligand）superfamily,
member 10
Tumor nectosis factor（ligand）superfamily,
member12
Tumor necrosis factor（ligand）superfamily,
member5
Tumor necrosis factor（ligand）superfamily,
member6
TNFRSF1A-associated via death domain
Transformation related protein 63
Transformation related protein73（predicted）
Functional Gene Grouping
TNF receptor family/p53
family/NF-kappa B
TNF receptor family/
Death domain family
TNF receptor family
TNF receptor family
TNF ligand family
TNF ligand family
TNF ligand family
TNF ligand family
p53 family/NF-kappa B family
/Death domain
p53 family
p53 family
Fold changes
2.54
5.5
2.55
2.84
-3.83
-2.09
15.35
5.23.
-2.06
3.23
6.68
pvalue
0.0017
<0.0001
0.0037
0.0006
<0.0001
0.0049
<0.0001
<0.0001
0.0002
0.0005
0.0001
Figure 2 Significant changes in gene expression in cochlear
spiral ganglion neurons 3 hours after 100 μM mefloquine
treatment. The expression in 25 genes was increased, but the
expression in another 7 genes was decreased
·· 6
Journal of Otology 2011 Vol.6 No.1
also crucial members in the DNA damage / p53 family,
Death domain / Death effector domain family, and
NF-kappa B family. 22 All members in the Card family
possess the caspase recruitment domain which is un⁃
doubtedly linked to the Caspase family. In addition, all
members in the IAP family serve as endogenous inhibi⁃
tors of programmed cell death, especially binding and
inhibiting activation of caspases to prevent apoptosis.
Therefore, the IAP family is characterized as worthy op⁃
ponent of caspases, and its activation indirectly reflects
caspases in a state of action. Apoptosis regulator Bcl-2
family governs mitochondrial outer membrane permea⁃
bility. Thus, changes in gene expression in the Bcl-2
family are thought to be in connection with mitochondri⁃
al degeneration. Moreover, many genes in the Bcl-2
family are also crucial members as strong prognostic in⁃
dicators related to p53 signaling pathway. 23 The p53
pathway and its complex are hereby believed to interact
with the Bcl-2 family as well. 24, 25 The mitochondrial
pathway of apoptotic functions can be also triggered in
response to various intracellular stress, such as the p53
signaling pathway, DNA damage, Death receptor stimu⁃
lations, as well as reversed stimuli from the TNF ligand
/ receptor family, which triggers activation of a caspase
cascade that shifts the balance in the Bcl-2 family. 26, 27
All factors and approaches should be taken into consid⁃
erations in apoptotic signaling in the mitochondrial
pathway, including its upstream, downstream, and other
surrounding pathways.
In our previous studies, we have shown that meflo⁃
quine damages rat cochlear hair cells and spiral gangli⁃
on neurons in a dose-dependent manner. In addition,
the initiator caspase-8 was activated 24 h after 35 μM
mefloquine treatment in response to apoptotic signaling
from the cell death receptors in the cell membrane. An⁃
other initiator caspase-9 was also activated in response
to cytochrome c release from damaged mitochondria,
which interacted with Apaf-1, causing self-cleavage of
caspase-9. These two initiator caspases, caspase-8 and
caspae-9 then activated their downstream executioner
caspase-3 to cleave various targets leading to cell apop⁃
tosis. These findings suggest that mefloquine-induced
apoptotic signals in caspase pathway may initiate from
two aspects: damage to the cell membrane and damage
to the mitocho-ndria. 12, 19, 21 Using RT-PCR apopto⁃
sis-focused gene array to detect changes in apopto⁃
sis-related genes 3 hours post-100 μM mefloquine, we
found that nine of the 23 responding genes in the co⁃
chlear basilar membrane, and twelve of the 32 respond⁃
ing genes in the spiral ganglion neurons belonged to or
were related to the tumor necrosis factor supper family,
consistent with our previous findings in caspase-8 acti⁃
vation 24 hours after mefloquine treatment. 2, 19, 21 In ad⁃
dition, numerous responding genes directly belong to or
are indirectly related to the apoptotic mitochondrial
pathway, such as Apaf1, Bcl2a1, BCl2l11, Bid3, Birc1b,
Birc3, Birc4, Bnip1, Casp1, Casp7, Casp9, Cradd, Mcl1,
TNF, etc. These responding genes are in conformity
with the post-mefloquine caspase-9 activation reported
in our previous publications. 12, 19, 21 Therefore, the tumor
necrosis factor pathway and the mitochondrial pathway
are considered to be the major apoptotic pathways in
mefloquine-induced cell apoptosis in the cochlear basi⁃
lar membrane and spiral ganglion neurons. Although
changes in gene expression showed a significant over⁃
lap between the cochlear basilar membrane and spiral
ganglion neurons, indicating that the major apoptotic
pathways in the two structures, differences exist which
may reflect the unique response in each tissue.
Changes in a wide range of apoptotic and anti-apop⁃
totic signals in the cochlear basilar membrane（hair
cells and supporting cells）and spiral ganglion neurons
are observed in the current study. Changes in apopto⁃
sis-related gene expression suggest potential changes
at mRNA level in response to mefloquine-induced ear⁃
ly apoptotic injury. While infringement of mefloquine
can alter gene expression, it may not affect the function
of the proteins made by the corresponding genes at the
same time. Recently, we have assayed changes in the
same model treated with 100 μM mefloquine for 3
hours, using an apoptosis-related antibody microarray.
The proteomic analysis revealed much less expressive
changes in apoptosis-related signaling proteins than in
mRNA, 28 indicating that gene changes always take pre⁃
cedence of functional changes in protein. It may also
suggest a possibility of important translational control of
the balance between the anti-apoptotic and the apoptot⁃
ic responses. In our proteomic studies, some responding
apoptosis-related proteins were a response or partial re⁃
sponse to caspases activities and changes of gene ex⁃
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pressions. For example, one of the responding proteins,
mitogen-activated protein kinase, was greatly in⁃
creased, suggesting the kinase cascade due to apoptotic
signal stimulationfrom the cellular surface to the DNA
in the nucleus. 29 This result is definitely consistent
with caspase-8 activity and nuclear destruction we dis⁃
covered in our previous studies 12, 19, 21 and with changes
in gene expression in the TNF ligand／receptor family,
caspase family, and DNA damage／p53 super family
observed in the current study. In addition, decreased
Caspase-3 protein expression at 3 hours post-meflo⁃
quine 28 may represent temporary suppression of execu⁃
tioner caspase-3 due to increased activities of an⁃
ti-apoptotic genes in the IAP family and Bcl-2 family
at the early stage of apoptosis.
In summary, the data from this study indicate that nu⁃
merous pro-apoptotic and anti-apoptotic genes in the
cochlear epithelium and spiral ganglion neurons are
rapidly activated in response to mefloquine-induced
apoptosis. Although multiple apoptotic pathways may
be aroused by mefloquine injury, the death recep⁃
tor-mediated signaling pathway and the mitochondrial
pathway seem to be the major accesses of apoptotic
pathways in mefloquine-induced cochlear apoptosis.
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